Orgenesis (ORGS) Insider Trading & Ownership $1.39 -0.21 (-13.13%) As of 01/17/2025 03:42 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestSustainabilityTrends Orgenesis (NASDAQ:ORGS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.66%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$25,783.00Number OfInsiders Selling(Last 12 Months)0 Get ORGS Insider Trade Alerts Want to know when executives and insiders are buying or selling Orgenesis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ORGS Insider Buying and Selling by Quarter Orgenesis Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/1/2024Jacob SafierMajor ShareholderBuy1,010$3.30$3,333.00 1/30/2024Jacob SafierMajor ShareholderBuy2,500$3.30$8,250.00 1/25/2024Jacob SafierMajor ShareholderBuy2,500$3.20$8,000.00 1/22/2024Jacob SafierMajor ShareholderBuy1,000$2.90$2,900.00 1/18/2024Jacob SafierMajor ShareholderBuy1,000$3.30$3,300.00 (Data available from 1/1/2013 forward) ORGS Insider Trading Activity - Frequently Asked Questions Who is on Orgenesis's Insider Roster? The list of insiders at Orgenesis includes Jacob Safier. Learn more on insiders at ORGS. What percentage of Orgenesis stock is owned by insiders? 5.66% of Orgenesis stock is owned by insiders. Learn more on ORGS's insider holdings. Which Orgenesis insiders have been buying company stock? The following insider purchased ORGS shares in the last 24 months: Jacob Safier ($29,483.00). How much insider buying is happening at Orgenesis? Insiders have purchased a total of 9,010 ORGS shares in the last 24 months for a total of $29,483.00 bought. Orgenesis Key ExecutivesMs. Vered Caplan M.Sc. (Age 55)Chairperson of the Board, CEO & President Compensation: $341.38kProf. Sarah Ferber Ph.D. (Age 70)Founder & Chief Scientific Officer Compensation: $268.32kMr. Victor Miller (Age 54)CFO, Secretary & Treasurer Pierre LammeretzInterim Chief Operating OfficerDr. Shimon Hassin Ph.D.Chief Technology OfficerMr. Evan FishmanChief Financial Officer of Orgenesis BiotechMr. Joseph CarpinelliChief Financial Officer of Octomera More Insider Trading Tools from MarketBeat Related Companies Cognition Therapeutics Insider Trades CEL-SCI Insider Trades MiNK Therapeutics Insider Trades KALA BIO Insider Trades Marinus Pharmaceuticals Insider Trades Unity Biotechnology Insider Trades Verrica Pharmaceuticals Insider Trades Mannatech Insider Trades Cadrenal Therapeutics Insider Trades Chemomab Therapeutics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:ORGS) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredElon's "Final Move" Could Send This Stock SoaringWhenever Elon Musk starts a new venture... Early investors get the opportunity to become millionaires... ...Behind the Markets | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orgenesis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orgenesis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ORGS Stock Alerts